These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7950290)

  • 21. Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor-induced destruction of red cells sensitized by IgG.
    Engelfriet CP; Overbeeke MA; Dooren MC; Ouwehand WH; von dem Borne AE
    Transfusion; 1994 Jul; 34(7):617-26. PubMed ID: 8053042
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D; Lazarus AH
    Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the ability of red cells sensitized with a bispecific anti-D x anti-Fc gamma RIII Fab fragment to activate human K cells and peritoneal macrophages through Fc gamma RIII.
    Bakács T; Hadley AG; Kumpel BM; Segal DM; Banhidy F
    Immunol Lett; 1994 Sep; 42(1-2):91-5. PubMed ID: 7829136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immune destruction of red cells.
    Engelfriet CP
    Transfus Med; 1992 Mar; 2(1):1-6. PubMed ID: 1308459
    [No Abstract]   [Full Text] [Related]  

  • 29. Rosetting, phagocytosis and immune red cell damage.
    Zupańska B
    Clin Lab Haematol; 1990; 12(3):309-20. PubMed ID: 2125543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An animal model for hemolytic disease of the fetus and newborn. I. Alloimmunization techniques.
    Moise KJ; Rodkey LS; Saade G; Gei A; Duré M; Graham A; Creech C
    Am J Obstet Gynecol; 1995 Jul; 173(1):51-5. PubMed ID: 7631726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of the isoantigen A2 and immune anti-A1 antibodies in transfusiology].
    Dashkova NG; Ragimov AA; Asoskova TK
    Anesteziol Reanimatol; 2009; (6):62-5. PubMed ID: 20099652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental erythroblastosis fetalis in rabbits. II. The passage of blood group antigens and their specific isoantibodies across the placenta.
    KELLNER A; HEDAL EF
    J Exp Med; 1953 Jan; 97(1):51-60. PubMed ID: 13022861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen topography is critical for interaction of IgG2 anti-red-cell antibodies with Fc gamma receptors.
    Kumpel BM; van de Winkel JG; Westerdaal NA; Hadley AG; Dugoujon JM; Blancher A
    Br J Haematol; 1996 Jul; 94(1):175-83. PubMed ID: 8757532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of functional assays for assessing the red cell antibody activity.
    Zupańska B
    Transfus Sci; 1993 Oct; 14(4):371-81. PubMed ID: 10146644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohematological study in newborn infants with erythroblastosis fetalis transfused in utero.
    Ancora G; Dallacasa P; Gavella B; Calderoni L; Nucci S; Belletti D; Sorci NA; Conte R; Salvioli GP
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():99-102. PubMed ID: 10021725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemolytic disease of the newborn probably due to anti-ELO, an antibody to a low frequency red cell antigen.
    Ford DS; Stern DA; Hawksworth DN; Lubenko A; Pope JM; Chana HS; Better PJ
    Vox Sang; 1992; 62(3):169-72. PubMed ID: 1609518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NA1/NA2 antisera inhibit FcgammaRI- but not FcgammaRII- mediated phagocytosis.
    Flesch BK; Maass W; Neppert J
    Vox Sang; 1998; 75(3):247-52. PubMed ID: 9852415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild course of fetal RhD haemolytic disease due to maternal alloimmunisation to paternal HLA class I and II antigens.
    Eichler H; Zieger W; Neppert J; Kerowgan M; Melchert F; Goldmann SF
    Vox Sang; 1995; 68(4):243-7. PubMed ID: 7660645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.